{"id":17101,"date":"2020-11-04T10:25:35","date_gmt":"2020-11-04T15:25:35","guid":{"rendered":"https:\/\/medicarereport.org\/?p=17101"},"modified":"2020-11-04T10:25:35","modified_gmt":"2020-11-04T15:25:35","slug":"missouri-drugmaker-latest-to-recall-metformin-over-carcinogen","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=17101","title":{"rendered":"Missouri drugmaker latest to recall metformin over carcinogen"},"content":{"rendered":"<p>(By\u00a0Maia Anderson for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n<p>A Kansas City, Mo.-based drugmaker, Nostrum Laboratories, has become the latest company to recall its diabetes drug, metformin, after finding it contains unacceptably high levels of a carcinogen.\u00a0 Continue reading article <a href=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/missouri-drugmaker-latest-to-recall-metformin-over-carcinogen.html\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-7795\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs-300x201.jpg\" alt=\"\" width=\"300\" height=\"201\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs-300x201.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs.jpg 700w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By\u00a0Maia Anderson for Becker&#8217;s Hospital Review) A Kansas City, Mo.-based drugmaker, Nostrum Laboratories, has become the latest company to recall<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-17101","post","type-post","status-publish","format-standard","hentry","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17101"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17101\/revisions"}],"predecessor-version":[{"id":17102,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17101\/revisions\/17102"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}